ORIC Pharmaceuticals, Inc. ORIC

US Biotechnology

$8.93 ▼ -3.25% ($-0.30)

🔥 High Short Interest 📅 Earnings This Week

Open $9.14

Prev Close $9.23

Day Range $8.79 – $9.46

52W Range $7.23 – $14.68

Market Cap $956.71M

Beta 1.18

EPS (TTM) $-1.35

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-04-24
Shares Out.	103,650,000
Website	oricpharma.com/ ↗
Phone	13026587581
Employees	111
Revenue	$0
Gross Profit	$0
Net Income	-$41.5M
Free Cash Flow	-$112.3M
Total Assets	$404.7M
Total Liabilities	$23.4M
Equity	$381.3M

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

ORIC Pharmaceuticals, Inc. is a publicly traded company under the ticker symbol ORIC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.